Table 6.
Follow-up of 51 patients
| Parameters | D1gastrectomy n (%) | D2 gastrectomy n (%) |
|---|---|---|
| Duration of follow-up(months) | ||
| Mean | 11.9 | 8.9 |
| Range | 2–22 | 3–21 |
| Concurrent chemoradiotherapy | 25 (75.8) | 7 (38.9) |
| Adjuvant radiotherapy only | 0 (0.0) | 2 (11.1) |
| Adjuvant chemotherapy only | 2 (6.1) | 1 (5.6) |
| Not fit for chemoradiotherapy | 5 (15.2) | 1 (5.6) |
| Only on follow-up | 1 (3.0) | 7 (38.9) |
| Complications during follow-up | ||
| Adhesive intestinal obstruction | 1 (3.0 ) | 2 (11.1 ) |
| Diarrhoea | 1 (3.0 ) | 1 ( 5.6) |
| Recurrence during follow-up | 2 (6.1) | 1 (5.6) |
| Recurrence period | ||
| 5 months | 0 (0.0) | 1 (5.6) |
| 9 months | 1 (3.0) | 0 (0.0) |
| 18 months | 1 (3.0) | 0 (0.0) |
| Died during follow-up | 11 (33.3) | 2 (11.1) |
| Time of death during follow-up | ||
| 3 months | 3 (9.1) | 0 (0.0) |
| 6 months | 0 (0.0) | 2 (11.1) |
| 9 months | 3 (9.1) | 0 (0.0) |
| 12 months | 3 (9.1) | 0 (0.0) |
| 22 months | 2 (6.1) | 0 (0.0) |
| Total deaths during study period | 12 (35.3) | 2 (11.1) |
| Lost follow up | 0 | 0 |
| Total patients followed up | 33 (100) | 18 (100) |